AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline ...

Shares in AbbVie have slumped after a pair of failed phase 2 trials for emraclidine, a schizophrenia drug it acquired as part of its $8.7 billion takeover of Cerevel Therapeutics last year.

Neurocrine's drug acts as a muscarinic M4 selective agonist, while KarXT targets M1 and M4 receptors and emraclidine is described as a muscarinic M4 receptor-positive allosteric modulator (PAM).

Reuters.com is your online source for the latest Middle-East news stories and current events, ensuring our readers up to date with any breaking news developments ...

Follow the latest Immigration news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to Immigration notifications.

Meta announces actions to fight "nudify" apps. Here's what to know. Meta said Thursday that it's suing an app maker that uses artificial intelligence to simulate nude images of real people who ...

Find latest cybersecurity news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

An LA news station sparked controversy after its anchor described anti-ICE riots as "people having fun watching cars burn" while violence erupted downtown.

ABC News correspondent Terry Moran is out after he was suspended over a viral social media post attacking President Donald Trump and his top aide Stephen Miller.

Americans now navigate a quickly changing information environment, with a wide variety of news sources across many different platforms and channels. We asked Americans about 30 specific news sources – ...